Pharma & Healthcare
Global Metabotropic Glutamate Receptor 2 Market Research Report 2025
- Sep 18, 25
- ID: 9366
- Pages: 85
- Figures: 80
- Views: 43
Report Scope
This report aims to provide a comprehensive presentation of the global market for Metabotropic Glutamate Receptor 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabotropic Glutamate Receptor 2.
The Metabotropic Glutamate Receptor 2 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metabotropic Glutamate Receptor 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabotropic Glutamate Receptor 2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
Segment by Type
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others
Segment by Application
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metabotropic Glutamate Receptor 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metabotropic Glutamate Receptor 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Metabotropic Glutamate Receptor 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabotropic Glutamate Receptor 2.
The Metabotropic Glutamate Receptor 2 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metabotropic Glutamate Receptor 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabotropic Glutamate Receptor 2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
Segment by Type
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others
Segment by Application
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metabotropic Glutamate Receptor 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metabotropic Glutamate Receptor 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Metabotropic Glutamate Receptor 2 Market Overview
1.1 Product Definition
1.2 Metabotropic Glutamate Receptor 2 by Type
1.2.1 Global Metabotropic Glutamate Receptor 2 Market Value Comparison by Type (2024 VS 2031)
1.2.2 LY-2607540
1.2.3 BMT-133218
1.2.4 DT-2442
1.2.5 JNJ-40411813
1.2.6 Others
1.3 Metabotropic Glutamate Receptor 2 by Application
1.3.1 Global Metabotropic Glutamate Receptor 2 Market Value by Application (2024 VS 2031)
1.3.2 Anxiety Disorders
1.3.3 Depression
1.3.4 Schizophrenia
1.3.5 Chronic Pain
1.3.6 Others
1.4 Global Metabotropic Glutamate Receptor 2 Market Size Estimates and Forecasts
1.4.1 Global Metabotropic Glutamate Receptor 2 Revenue 2020-2031
1.4.2 Global Metabotropic Glutamate Receptor 2 Sales 2020-2031
1.4.3 Global Metabotropic Glutamate Receptor 2 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Metabotropic Glutamate Receptor 2 Market Competition by Manufacturers
2.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Metabotropic Glutamate Receptor 2 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Metabotropic Glutamate Receptor 2, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Product Type & Application
2.7 Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Date of Enter into This Industry
2.8 Global Metabotropic Glutamate Receptor 2 Market Competitive Situation and Trends
2.8.1 Global Metabotropic Glutamate Receptor 2 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Metabotropic Glutamate Receptor 2 Players Market Share by Revenue
2.8.3 Global Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Metabotropic Glutamate Receptor 2 Market Scenario by Region
3.1 Global Metabotropic Glutamate Receptor 2 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Metabotropic Glutamate Receptor 2 Sales by Region: 2020-2031
3.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Region: 2020-2025
3.2.2 Global Metabotropic Glutamate Receptor 2 Sales by Region: 2026-2031
3.3 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2020-2031
3.3.1 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2020-2025
3.3.2 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2026-2031
3.4 North America Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country
3.4.1 North America Metabotropic Glutamate Receptor 2 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Metabotropic Glutamate Receptor 2 Sales by Country (2020-2031)
3.4.3 North America Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country
3.5.1 Europe Metabotropic Glutamate Receptor 2 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2020-2031)
3.5.3 Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metabotropic Glutamate Receptor 2 Market Facts & Figures by Region
3.6.1 Asia Pacific Metabotropic Glutamate Receptor 2 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2020-2031)
3.6.3 Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country
3.7.1 Latin America Metabotropic Glutamate Receptor 2 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2020-2031)
3.7.3 Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Metabotropic Glutamate Receptor 2 Sales by Type (2020-2031)
4.1.1 Global Metabotropic Glutamate Receptor 2 Sales by Type (2020-2025)
4.1.2 Global Metabotropic Glutamate Receptor 2 Sales by Type (2026-2031)
4.1.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2020-2031)
4.2 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2020-2031)
4.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2020-2025)
4.2.2 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2026-2031)
4.2.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2020-2031)
4.3 Global Metabotropic Glutamate Receptor 2 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Metabotropic Glutamate Receptor 2 Sales by Application (2020-2031)
5.1.1 Global Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025)
5.1.2 Global Metabotropic Glutamate Receptor 2 Sales by Application (2026-2031)
5.1.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2020-2031)
5.2 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2020-2031)
5.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2020-2025)
5.2.2 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2026-2031)
5.2.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2020-2031)
5.3 Global Metabotropic Glutamate Receptor 2 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Addex Therapeutics Ltd
6.1.1 Addex Therapeutics Ltd Company Information
6.1.2 Addex Therapeutics Ltd Description and Business Overview
6.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Portfolio
6.1.5 Addex Therapeutics Ltd Recent Developments/Updates
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Company Information
6.2.2 Bristol-Myers Squibb Company Description and Business Overview
6.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Portfolio
6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.3 Denovo Biopharma LLC
6.3.1 Denovo Biopharma LLC Company Information
6.3.2 Denovo Biopharma LLC Description and Business Overview
6.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Portfolio
6.3.5 Denovo Biopharma LLC Recent Developments/Updates
6.4 Domain Therapeutics SA
6.4.1 Domain Therapeutics SA Company Information
6.4.2 Domain Therapeutics SA Description and Business Overview
6.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Portfolio
6.4.5 Domain Therapeutics SA Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Company Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck & Co Inc
6.7.1 Merck & Co Inc Company Information
6.7.2 Merck & Co Inc Description and Business Overview
6.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Portfolio
6.7.5 Merck & Co Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metabotropic Glutamate Receptor 2 Industry Chain Analysis
7.2 Metabotropic Glutamate Receptor 2 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metabotropic Glutamate Receptor 2 Production Mode & Process Analysis
7.4 Metabotropic Glutamate Receptor 2 Sales and Marketing
7.4.1 Metabotropic Glutamate Receptor 2 Sales Channels
7.4.2 Metabotropic Glutamate Receptor 2 Distributors
7.5 Metabotropic Glutamate Receptor 2 Customer Analysis
8 Metabotropic Glutamate Receptor 2 Market Dynamics
8.1 Metabotropic Glutamate Receptor 2 Industry Trends
8.2 Metabotropic Glutamate Receptor 2 Market Drivers
8.3 Metabotropic Glutamate Receptor 2 Market Challenges
8.4 Metabotropic Glutamate Receptor 2 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Metabotropic Glutamate Receptor 2 by Type
1.2.1 Global Metabotropic Glutamate Receptor 2 Market Value Comparison by Type (2024 VS 2031)
1.2.2 LY-2607540
1.2.3 BMT-133218
1.2.4 DT-2442
1.2.5 JNJ-40411813
1.2.6 Others
1.3 Metabotropic Glutamate Receptor 2 by Application
1.3.1 Global Metabotropic Glutamate Receptor 2 Market Value by Application (2024 VS 2031)
1.3.2 Anxiety Disorders
1.3.3 Depression
1.3.4 Schizophrenia
1.3.5 Chronic Pain
1.3.6 Others
1.4 Global Metabotropic Glutamate Receptor 2 Market Size Estimates and Forecasts
1.4.1 Global Metabotropic Glutamate Receptor 2 Revenue 2020-2031
1.4.2 Global Metabotropic Glutamate Receptor 2 Sales 2020-2031
1.4.3 Global Metabotropic Glutamate Receptor 2 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Metabotropic Glutamate Receptor 2 Market Competition by Manufacturers
2.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Metabotropic Glutamate Receptor 2 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Metabotropic Glutamate Receptor 2, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Product Type & Application
2.7 Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Date of Enter into This Industry
2.8 Global Metabotropic Glutamate Receptor 2 Market Competitive Situation and Trends
2.8.1 Global Metabotropic Glutamate Receptor 2 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Metabotropic Glutamate Receptor 2 Players Market Share by Revenue
2.8.3 Global Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Metabotropic Glutamate Receptor 2 Market Scenario by Region
3.1 Global Metabotropic Glutamate Receptor 2 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Metabotropic Glutamate Receptor 2 Sales by Region: 2020-2031
3.2.1 Global Metabotropic Glutamate Receptor 2 Sales by Region: 2020-2025
3.2.2 Global Metabotropic Glutamate Receptor 2 Sales by Region: 2026-2031
3.3 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2020-2031
3.3.1 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2020-2025
3.3.2 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2026-2031
3.4 North America Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country
3.4.1 North America Metabotropic Glutamate Receptor 2 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Metabotropic Glutamate Receptor 2 Sales by Country (2020-2031)
3.4.3 North America Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country
3.5.1 Europe Metabotropic Glutamate Receptor 2 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2020-2031)
3.5.3 Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metabotropic Glutamate Receptor 2 Market Facts & Figures by Region
3.6.1 Asia Pacific Metabotropic Glutamate Receptor 2 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2020-2031)
3.6.3 Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country
3.7.1 Latin America Metabotropic Glutamate Receptor 2 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2020-2031)
3.7.3 Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Metabotropic Glutamate Receptor 2 Sales by Type (2020-2031)
4.1.1 Global Metabotropic Glutamate Receptor 2 Sales by Type (2020-2025)
4.1.2 Global Metabotropic Glutamate Receptor 2 Sales by Type (2026-2031)
4.1.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2020-2031)
4.2 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2020-2031)
4.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2020-2025)
4.2.2 Global Metabotropic Glutamate Receptor 2 Revenue by Type (2026-2031)
4.2.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2020-2031)
4.3 Global Metabotropic Glutamate Receptor 2 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Metabotropic Glutamate Receptor 2 Sales by Application (2020-2031)
5.1.1 Global Metabotropic Glutamate Receptor 2 Sales by Application (2020-2025)
5.1.2 Global Metabotropic Glutamate Receptor 2 Sales by Application (2026-2031)
5.1.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2020-2031)
5.2 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2020-2031)
5.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2020-2025)
5.2.2 Global Metabotropic Glutamate Receptor 2 Revenue by Application (2026-2031)
5.2.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2020-2031)
5.3 Global Metabotropic Glutamate Receptor 2 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Addex Therapeutics Ltd
6.1.1 Addex Therapeutics Ltd Company Information
6.1.2 Addex Therapeutics Ltd Description and Business Overview
6.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Portfolio
6.1.5 Addex Therapeutics Ltd Recent Developments/Updates
6.2 Bristol-Myers Squibb Company
6.2.1 Bristol-Myers Squibb Company Company Information
6.2.2 Bristol-Myers Squibb Company Description and Business Overview
6.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Portfolio
6.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.3 Denovo Biopharma LLC
6.3.1 Denovo Biopharma LLC Company Information
6.3.2 Denovo Biopharma LLC Description and Business Overview
6.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Portfolio
6.3.5 Denovo Biopharma LLC Recent Developments/Updates
6.4 Domain Therapeutics SA
6.4.1 Domain Therapeutics SA Company Information
6.4.2 Domain Therapeutics SA Description and Business Overview
6.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Portfolio
6.4.5 Domain Therapeutics SA Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Company Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck & Co Inc
6.7.1 Merck & Co Inc Company Information
6.7.2 Merck & Co Inc Description and Business Overview
6.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Portfolio
6.7.5 Merck & Co Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metabotropic Glutamate Receptor 2 Industry Chain Analysis
7.2 Metabotropic Glutamate Receptor 2 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metabotropic Glutamate Receptor 2 Production Mode & Process Analysis
7.4 Metabotropic Glutamate Receptor 2 Sales and Marketing
7.4.1 Metabotropic Glutamate Receptor 2 Sales Channels
7.4.2 Metabotropic Glutamate Receptor 2 Distributors
7.5 Metabotropic Glutamate Receptor 2 Customer Analysis
8 Metabotropic Glutamate Receptor 2 Market Dynamics
8.1 Metabotropic Glutamate Receptor 2 Industry Trends
8.2 Metabotropic Glutamate Receptor 2 Market Drivers
8.3 Metabotropic Glutamate Receptor 2 Market Challenges
8.4 Metabotropic Glutamate Receptor 2 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Metabotropic Glutamate Receptor 2 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Metabotropic Glutamate Receptor 2 Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Metabotropic Glutamate Receptor 2 Market Competitive Situation by Manufacturers in 2024
Table 4. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Metabotropic Glutamate Receptor 2 Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Metabotropic Glutamate Receptor 2 Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Metabotropic Glutamate Receptor 2, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Product Type & Application
Table 12. Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Metabotropic Glutamate Receptor 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 2 as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Metabotropic Glutamate Receptor 2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Metabotropic Glutamate Receptor 2 Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2020-2025)
Table 19. Global Metabotropic Glutamate Receptor 2 Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2026-2031)
Table 21. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2020-2025)
Table 23. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2026-2031)
Table 25. North America Metabotropic Glutamate Receptor 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Metabotropic Glutamate Receptor 2 Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Metabotropic Glutamate Receptor 2 Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Metabotropic Glutamate Receptor 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Metabotropic Glutamate Receptor 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2020-2025)
Table 51. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2026-2031)
Table 52. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2020-2025)
Table 53. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2026-2031)
Table 54. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2020-2025)
Table 57. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2026-2031)
Table 58. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2020-2025)
Table 61. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2026-2031)
Table 62. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2020-2025)
Table 63. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2026-2031)
Table 64. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2020-2025)
Table 67. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2026-2031)
Table 68. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Application (2026-2031)
Table 70. Addex Therapeutics Ltd Company Information
Table 71. Addex Therapeutics Ltd Description and Business Overview
Table 72. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product
Table 74. Addex Therapeutics Ltd Recent Developments/Updates
Table 75. Bristol-Myers Squibb Company Company Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product
Table 79. Bristol-Myers Squibb Company Recent Developments/Updates
Table 80. Denovo Biopharma LLC Company Information
Table 81. Denovo Biopharma LLC Description and Business Overview
Table 82. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product
Table 84. Denovo Biopharma LLC Recent Developments/Updates
Table 85. Domain Therapeutics SA Company Information
Table 86. Domain Therapeutics SA Description and Business Overview
Table 87. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product
Table 89. Domain Therapeutics SA Recent Developments/Updates
Table 90. Eli Lilly and Company Company Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product
Table 94. Eli Lilly and Company Recent Developments/Updates
Table 95. Johnson & Johnson Company Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Merck & Co Inc Company Information
Table 101. Merck & Co Inc Description and Business Overview
Table 102. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product
Table 104. Merck & Co Inc Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Metabotropic Glutamate Receptor 2 Distributors List
Table 108. Metabotropic Glutamate Receptor 2 Customers List
Table 109. Metabotropic Glutamate Receptor 2 Market Trends
Table 110. Metabotropic Glutamate Receptor 2 Market Drivers
Table 111. Metabotropic Glutamate Receptor 2 Market Challenges
Table 112. Metabotropic Glutamate Receptor 2 Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Metabotropic Glutamate Receptor 2
Figure 2. Global Metabotropic Glutamate Receptor 2 Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Metabotropic Glutamate Receptor 2 Market Share by Type: 2024 & 2031
Figure 4. LY-2607540 Product Picture
Figure 5. BMT-133218 Product Picture
Figure 6. DT-2442 Product Picture
Figure 7. JNJ-40411813 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Metabotropic Glutamate Receptor 2 Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Metabotropic Glutamate Receptor 2 Market Share by Application: 2024 & 2031
Figure 11. Anxiety Disorders
Figure 12. Depression
Figure 13. Schizophrenia
Figure 14. Chronic Pain
Figure 15. Others
Figure 16. Global Metabotropic Glutamate Receptor 2 Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Metabotropic Glutamate Receptor 2 Market Size (2020-2031) & (US$ Million)
Figure 18. Global Metabotropic Glutamate Receptor 2 Sales (2020-2031) & (K Pcs)
Figure 19. Global Metabotropic Glutamate Receptor 2 Average Price (USD/Pcs) & (2020-2031)
Figure 20. Metabotropic Glutamate Receptor 2 Report Years Considered
Figure 21. Metabotropic Glutamate Receptor 2 Sales Share by Manufacturers in 2024
Figure 22. Global Metabotropic Glutamate Receptor 2 Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Metabotropic Glutamate Receptor 2 Players: Market Share by Revenue in Metabotropic Glutamate Receptor 2 in 2024
Figure 24. Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Metabotropic Glutamate Receptor 2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2031)
Figure 27. North America Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2031)
Figure 31. Europe Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2031)
Figure 32. Germany Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2020-2031)
Figure 39. China Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2031)
Figure 50. Latin America Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. U.A.E Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Metabotropic Glutamate Receptor 2 by Type (2020-2031)
Figure 60. Global Revenue Market Share of Metabotropic Glutamate Receptor 2 by Type (2020-2031)
Figure 61. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Type (2020-2031)
Figure 62. Global Sales Market Share of Metabotropic Glutamate Receptor 2 by Application (2020-2031)
Figure 63. Global Revenue Market Share of Metabotropic Glutamate Receptor 2 by Application (2020-2031)
Figure 64. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Application (2020-2031)
Figure 65. Metabotropic Glutamate Receptor 2 Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Metabotropic Glutamate Receptor 2 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Metabotropic Glutamate Receptor 2 Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Metabotropic Glutamate Receptor 2 Market Competitive Situation by Manufacturers in 2024
Table 4. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Metabotropic Glutamate Receptor 2 Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Metabotropic Glutamate Receptor 2 Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Metabotropic Glutamate Receptor 2, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Product Type & Application
Table 12. Global Key Manufacturers of Metabotropic Glutamate Receptor 2, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Metabotropic Glutamate Receptor 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 2 as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Metabotropic Glutamate Receptor 2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Metabotropic Glutamate Receptor 2 Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2020-2025)
Table 19. Global Metabotropic Glutamate Receptor 2 Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2026-2031)
Table 21. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2020-2025)
Table 23. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2026-2031)
Table 25. North America Metabotropic Glutamate Receptor 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Metabotropic Glutamate Receptor 2 Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Metabotropic Glutamate Receptor 2 Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Metabotropic Glutamate Receptor 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Metabotropic Glutamate Receptor 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2020-2025)
Table 51. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Type (2026-2031)
Table 52. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2020-2025)
Table 53. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2026-2031)
Table 54. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2020-2025)
Table 57. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2026-2031)
Table 58. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2020-2025)
Table 61. Global Metabotropic Glutamate Receptor 2 Sales (K Pcs) by Application (2026-2031)
Table 62. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2020-2025)
Table 63. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2026-2031)
Table 64. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Metabotropic Glutamate Receptor 2 Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2020-2025)
Table 67. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2026-2031)
Table 68. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Application (2026-2031)
Table 70. Addex Therapeutics Ltd Company Information
Table 71. Addex Therapeutics Ltd Description and Business Overview
Table 72. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product
Table 74. Addex Therapeutics Ltd Recent Developments/Updates
Table 75. Bristol-Myers Squibb Company Company Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product
Table 79. Bristol-Myers Squibb Company Recent Developments/Updates
Table 80. Denovo Biopharma LLC Company Information
Table 81. Denovo Biopharma LLC Description and Business Overview
Table 82. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product
Table 84. Denovo Biopharma LLC Recent Developments/Updates
Table 85. Domain Therapeutics SA Company Information
Table 86. Domain Therapeutics SA Description and Business Overview
Table 87. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product
Table 89. Domain Therapeutics SA Recent Developments/Updates
Table 90. Eli Lilly and Company Company Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product
Table 94. Eli Lilly and Company Recent Developments/Updates
Table 95. Johnson & Johnson Company Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Merck & Co Inc Company Information
Table 101. Merck & Co Inc Description and Business Overview
Table 102. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product
Table 104. Merck & Co Inc Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Metabotropic Glutamate Receptor 2 Distributors List
Table 108. Metabotropic Glutamate Receptor 2 Customers List
Table 109. Metabotropic Glutamate Receptor 2 Market Trends
Table 110. Metabotropic Glutamate Receptor 2 Market Drivers
Table 111. Metabotropic Glutamate Receptor 2 Market Challenges
Table 112. Metabotropic Glutamate Receptor 2 Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Metabotropic Glutamate Receptor 2
Figure 2. Global Metabotropic Glutamate Receptor 2 Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Metabotropic Glutamate Receptor 2 Market Share by Type: 2024 & 2031
Figure 4. LY-2607540 Product Picture
Figure 5. BMT-133218 Product Picture
Figure 6. DT-2442 Product Picture
Figure 7. JNJ-40411813 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Metabotropic Glutamate Receptor 2 Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Metabotropic Glutamate Receptor 2 Market Share by Application: 2024 & 2031
Figure 11. Anxiety Disorders
Figure 12. Depression
Figure 13. Schizophrenia
Figure 14. Chronic Pain
Figure 15. Others
Figure 16. Global Metabotropic Glutamate Receptor 2 Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Metabotropic Glutamate Receptor 2 Market Size (2020-2031) & (US$ Million)
Figure 18. Global Metabotropic Glutamate Receptor 2 Sales (2020-2031) & (K Pcs)
Figure 19. Global Metabotropic Glutamate Receptor 2 Average Price (USD/Pcs) & (2020-2031)
Figure 20. Metabotropic Glutamate Receptor 2 Report Years Considered
Figure 21. Metabotropic Glutamate Receptor 2 Sales Share by Manufacturers in 2024
Figure 22. Global Metabotropic Glutamate Receptor 2 Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Metabotropic Glutamate Receptor 2 Players: Market Share by Revenue in Metabotropic Glutamate Receptor 2 in 2024
Figure 24. Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Metabotropic Glutamate Receptor 2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2031)
Figure 27. North America Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2031)
Figure 31. Europe Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2031)
Figure 32. Germany Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2020-2031)
Figure 39. China Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2031)
Figure 50. Latin America Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. U.A.E Metabotropic Glutamate Receptor 2 Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Metabotropic Glutamate Receptor 2 by Type (2020-2031)
Figure 60. Global Revenue Market Share of Metabotropic Glutamate Receptor 2 by Type (2020-2031)
Figure 61. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Type (2020-2031)
Figure 62. Global Sales Market Share of Metabotropic Glutamate Receptor 2 by Application (2020-2031)
Figure 63. Global Revenue Market Share of Metabotropic Glutamate Receptor 2 by Application (2020-2031)
Figure 64. Global Metabotropic Glutamate Receptor 2 Price (USD/Pcs) by Application (2020-2031)
Figure 65. Metabotropic Glutamate Receptor 2 Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232